Patents Assigned to Vampex Limited
  • Treatment of hyperproliferative diseases
    Patent number: 8048918
    Abstract: We describe methods and compositions for treating a patient suffering from a hyperproliferative disorder or photoageing. Our methods involve blocking the activity of a retinol binding protein receptor (RBPr) in cells of the patient, and/or administering to the patient an antagonist of a retinol binding protein receptor (RBPr) and/or lowering the endogenous level of retinoic acid (RA) in cells of said patient.
    Type: Grant
    Filed: February 27, 2002
    Date of Patent: November 1, 2011
    Assignee: Vampex Limited
    Inventors: Simon Ward, Claes Bavik, Michael Cork, Rachid Tazi-Aahnini